PALB2 and ovarian carcinoma: The entire coding sequence of the PALB2 gene was screened in 70 non-consecutive ovarian cancers only; the sensitivity of the SSCP ranges from 70% to 95%, according to different publications [27,28], and it is 90% in our laboratory [20].